ISEND May Predict Clinical Outcomes for Advanced NSCLC Patients on PD-1/PD-L1 Inhibitors but Not Chemotherapies or Targeted Kinase Inhibitors

被引：0

作者：

Park, W. ^{[1
]}

Kwon, D. ^{[2
]}

Desai, A. ^{[1
]}

Florou, V. ^{[1
]}

Saravia, D. ^{[3
]}

Warsch, J. ^{[4
]}

Chae, Y. K. ^{[5
]}

Ishkanian, A. ^{[6
]}

Jahanzeb, M. ^{[7
]}

Mudad, R. ^{[8
]}

Lopes, G. ^{[9
]}

机构：

[1] Univ Miami, Sylvester Comprehens Canc Ctr, Hematol & Oncol, Miami, FL USA

[2] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Med Biostat & Bioinformat, Miami, FL USA

[3] Univ Miami, Miller Sch Med, Internal Med, Miami, FL 33136 USA

[4] Univ Miami, Sylvester Comprehens Canc Ctr, Radiol, Miami, FL USA

[5] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Dev Therapeut Program, Chicago, IL 60611 USA

[6] Univ Miami, Sylvester Comprehens Canc Ctr, Radiat Oncol, Miami, FL USA

[7] Univ Miami, Sylvester Comprehens Canc Ctr, Med Oncol, Miami, FL USA

[8] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA

[9] Univ Miami, Sylvester Comprehens Canc Ctr, Global Oncol, Miami, FL USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期

关键词：

Predictive; PD-1; inhibitor; Clinical outcome;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.07-024

引用

页码：S2004 / S2004

页数：1

共 50 条

[31] Ocular adverse events in PD-1 and PD-L1 inhibitors
Young, LeAnne
Finnigan, Shanda
Streicher, Howard
Chen, Helen X.
Murray, James
Sen, H. Nida
Sharon, Elad
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
[32] Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Ming Yi
Dechao Jiao
Hanxiao Xu
Qian Liu
Weiheng Zhao
Xinwei Han
Kongming Wu
Molecular Cancer, 17
[33] PD-1/PD-L1 inhibitors increase risk of hepatitis
Reactions Weekly, 2020, 1809 (1) : 9 - 9
[34] Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Yi, Ming
Jiao, Dechao
Xu, Hanxiao
Liu, Qian
Zhao, Weiheng
Han, Xinwei
Wu, Kongming
MOLECULAR CANCER, 2018, 17
[35] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
Hayashi, Hidetoshi
Nakagawa, Kazuhiko
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 818 - 830
[36] Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma
Meghan M. Lynch
Borislav A. Alexiev
Brett A. Schroeder
Seth M. Pollack
Current Treatment Options in Oncology, 2022, 23 : 1861 - 1876
[37] Progress on biphenyl derivatives as PD-1/PD-L1 inhibitors
Wang, Shurong
Wang, Yuli
Yan, Hong
MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (10) : 2089 - 2115
[38] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
Hidetoshi Hayashi
Kazuhiko Nakagawa
International Journal of Clinical Oncology, 2020, 25 : 818 - 830
[39] Efficiency of PD-1 and PD-L1 Inhibitors in Malignant Therapy
Gappa, Birgit
Kobold, Sebastian
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (01) : 7 - 8
[40] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
Liu, Jinhua
Chen, Zichao
Li, Yaqun
Zhao, Wenjie
Wu, JiBiao
Zhang, Zhen
FRONTIERS IN PHARMACOLOGY, 2021, 12

← 1 2 3 4 5 →